Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
08/08/2007 | EP1814902A1 New cyclic peptide compound |
08/08/2007 | EP1814897A2 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
08/08/2007 | EP1814591A1 Bioactive compositions |
08/08/2007 | EP1814587A2 Purposeful movement of human migratory cells away from an agent source |
08/08/2007 | EP1814585A2 Methods and materials for the inhibition of transplant rejection |
08/08/2007 | EP1814582A1 A method of reducing drug-induced adverse side effects in a patient |
08/08/2007 | EP1814581A2 Stable formulations of peptides |
08/08/2007 | EP1814580A2 Methods of using il-21 for adoptive immunotherapy and identification of tumor antigens |
08/08/2007 | EP1814579A2 Mutated netrin-4, fragments thereof and their use as medicines |
08/08/2007 | EP1814578A2 Compositions and methods for treatment of protein misfolding and protein aggregation diseases |
08/08/2007 | EP1814577A2 Use of baff to treat sepsis |
08/08/2007 | EP1814576A2 Combination therapies of hmgb and complement inhibitors against inflammation |
08/08/2007 | EP1814575A2 Methods and compositions for treating conditions |
08/08/2007 | EP1814574A2 Adrenocorticotropic hormone analogs and related methods |
08/08/2007 | EP1814573A2 Remodeling and glycopegylation of fibroblast growth factor (fgf) |
08/08/2007 | EP1814572A1 Prevention of vertical endoparasite infections |
08/08/2007 | EP1814571A2 In situ method for treatment and repair of meniscal injuries |
08/08/2007 | EP1814569A2 Glycolipids |
08/08/2007 | EP1814568A2 Combination cancer immunotherapy with co-stimulatory molecules |
08/08/2007 | EP1814567A1 Use of modulators of epha2 and ephrina1 for the treatment and prevention of infections |
08/08/2007 | EP1814566A2 Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds |
08/08/2007 | EP1814565A1 Use of pentamers for producing a medicament |
08/08/2007 | EP1814394A2 Use of antioxidants for gene modulation |
08/08/2007 | EP1723172B1 Erythropoietin liquid formulation |
08/08/2007 | EP1668360A4 Multifactorial assay for cancer detection |
08/08/2007 | EP1660656B1 An antisense oligonucleotide to inhibit melanoma inhibitory activity, mia |
08/08/2007 | EP1615656B1 Immunomodulatory product obtained from a bifidobacterium culture and compositions containing the same |
08/08/2007 | EP1587510A4 Method for treating ischemic stroke with melatonin |
08/08/2007 | EP1575515A4 Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor |
08/08/2007 | EP1575490A4 Modified glucagon-like peptide-1 analogs |
08/08/2007 | EP1474423B1 Heterocyclic tripeptides as hepatitis c inhibitors |
08/08/2007 | EP1456382B1 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins |
08/08/2007 | EP1451219B1 Nuclear protein "shoca" - a component of the wnt signalling pathway |
08/08/2007 | EP1441717B1 Combination of an atp-competitive inhibitor of bcr/abl kinase activity and a tyrphostin analog |
08/08/2007 | EP1359902B1 Bimodal dry powder formulation for inhalation |
08/08/2007 | EP1354890B1 Chordin-like polypeptides and dna thereof |
08/08/2007 | EP1268424B1 Method for synthesis of perindopril and its pharmaceutically acceptable salts |
08/08/2007 | EP1267616B1 Methods of increasing hair growth by wnt polypeptide |
08/08/2007 | EP1187852B1 EXPRESSION AND EXPORT OF INTERFERON-ALPHA PROTEINS AS Fc FUSION PROTEINS |
08/08/2007 | EP1122306B1 Novel deoxyribonuclease, gene encoding the same and use thereof |
08/08/2007 | EP1113807B1 Cell mediated gene delivery using muscle derived cells for treating muscle- and bone-related injury or dysfunction |
08/08/2007 | EP1108035B1 Treatment of cervical cancer |
08/08/2007 | EP1100816B1 Aerothricin analogs, their preparation and use |
08/08/2007 | EP1092772B1 Antibody against lar phosphatase subunit |
08/08/2007 | EP1039804A4 Method for treating fibroproliferative disorders by inhibitors of protein hydroxylation |
08/08/2007 | EP0910402B1 Insulin preparations containing mannitol |
08/08/2007 | EP0882065B1 Novel human metabotropic glutamate receptor |
08/08/2007 | EP0843516B1 Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits |
08/08/2007 | EP0837129B1 Epimorphin antagonist and process for producing the same |
08/08/2007 | EP0812331B2 Mhc-antigen complexes for detecting and purifying antigen-specific t cells |
08/08/2007 | EP0706376B2 Anti-angiogenic compositions and methods of use |
08/08/2007 | CN1330758C Antifungal polypeptide and its preparation method |
08/08/2007 | CN1330754C Ligand 0(cluding antibody) for display aimed-at endocrine cell reactivity |
08/08/2007 | CN1330669C Recombinant targeted infuse protein for promoting thrombocytopoiesis and its preparation method |
08/08/2007 | CN1330667C Method for isolating an intestinal cholesterol binding protein |
08/08/2007 | CN1330666C Hypoxia-inducible factor I-alpha HIF-I-alpha variants and methods for identifying HIF-I-alpha modulators |
08/08/2007 | CN1330638C Substituted imidazolidine derivatives, their prepn., their use and pharmaceutical prepn. comprising them |
08/08/2007 | CN1330377C Peptide-base immunotherapeutic agent for allergic diseases |
08/08/2007 | CN1330375C Humanized antibodies that recognize verotoxin II and cell line producing same |
08/08/2007 | CN1330374C Method for preparing nano freeze-dried powder comprising human-body calcitonin gene relative peptide and product made therefrom and use thereof |
08/08/2007 | CN1330373C Medicine composition containing alfa-interferon , adefovir and FTC |
08/08/2007 | CN1330372C Stabilized Inteferon compsns |
08/08/2007 | CN1330371C Recombinant human epidermal growth factor compound biological agent and its use |
08/08/2007 | CN1330370C Stabilized albumin preparaions |
08/08/2007 | CN101014711A Production of tissue factor in plants |
08/08/2007 | CN101014701A Cartilage and bone repair composition. |
08/08/2007 | CN101014613A Chimpanzee adenovirus vaccine carriers |
08/08/2007 | CN101014612A Compounds for proteasome enzyme inhibition |
08/08/2007 | CN101014611A Improved aprotinin variants |
08/08/2007 | CN101014361A Chronic articular inflammation-modulating composition based on collagen-polyvinylpyrrolidone |
08/08/2007 | CN101014360A Antidiabetic oral insulin-biguanide combination |
08/08/2007 | CN101014359A Method of treating parkinson's disease in humans by direct infusion of glial cell-line derived neurotrophic factor into the zona incerta |
08/08/2007 | CN101014358A Biological activity of pigment epithelium-derived factor and methods of use |
08/08/2007 | CN101014357A Combination therapies employing platelet aggregation drugs |
08/08/2007 | CN101014356A Oligopeptides for reducing elevated blood urea concentration |
08/08/2007 | CN101014355A Methods and compositions for treatment of autoimmune diseases |
08/08/2007 | CN101014354A A method of pre-sensitizing cancer prior to treament with radiation and/or chemotherapy and a novel cytokine mixture |
08/08/2007 | CN101014353A Combination therapy comprising cloretazine(tm) |
08/08/2007 | CN101014329A Method of effectively using medicine and method concerning prevention of side effect |
08/08/2007 | CN101014317A Ophthalmic emulsions containing an immunosuppressive agent |
08/08/2007 | CN101012458A Expression system |
08/08/2007 | CN101012455A Deactivation method of biochemistry substance, preparing method of cardiomyopeptidin and use of cardiomyopeptidin |
08/08/2007 | CN101012281A Recombination expression and application of blood sugar reducing peptide and human albumin |
08/08/2007 | CN101012278A Rana grahami anti-microorganism polypeptide, gene thereof and application in pharmacy |
08/08/2007 | CN101012277A Rana grahami skin active peptide, gene thereof and application in pharmacy |
08/08/2007 | CN101012276A Rana grahami antiblastic peptide, gene and variant thereof, and application in pharmacy |
08/08/2007 | CN101012275A Rana grahami skin peptide, gene thereof and application in pharmacy |
08/08/2007 | CN101012274A Rana grahami peptide, gene thereof and application in pharmacy |
08/08/2007 | CN101012273A Rana grahami secretory peptide, gene thereof and application in pharmacy |
08/08/2007 | CN101011596A Process for preparing antibiotic-peptide modified-fibroin film material |
08/08/2007 | CN101011584A Method for achieving persistent transgene expression |
08/08/2007 | CN101011574A Use of an anti-il6 receptor antibody for preparing pharmaceutical composition |
08/08/2007 | CN101011573A Production of high molecular mass lectins |
08/08/2007 | CN101011572A Medicinal composition of recombinant human parathormone(1-84) and its preparing process |
08/08/2007 | CN101011571A Use of GADD45 beta protein and its inhibitor in treatment of rheumatoid arthritis |
08/08/2007 | CN101011570A Recombinant Xinjiang cultivated silkworm antimicrobial peptide preparation, its production method and use thereof in aviculture |
08/08/2007 | CN101011569A Method for diagnosing and treating type II dentinogenesis by using DSPP gene and encoding product thereof |
08/08/2007 | CN101011568A Immuno-modulatory agents with function of preventing and curing type 2 diabetes |
08/08/2007 | CN101011567A Medicament for treating AIDS and its preparing method |
08/08/2007 | CN101011392A Amino acid composition for enhancing traumatic organism growth factor expression and oxidation resistance function |